Trials / Completed
CompletedNCT02913794
Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control
A Single-center Cross-sectional Study to Evaluate the Effectiveness of Antihypertensive Treatment Including Fimasartan and the Dyslipidemia Treatment Including Rosuvastatin and to Assess the Association Between the Two Treatments
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 541 (actual)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Fimasartan and Rosuvastatin for hypertension and dyslipidemia control
Conditions
Timeline
- Start date
- 2016-10-11
- Primary completion
- 2018-03-29
- Completion
- 2018-03-29
- First posted
- 2016-09-26
- Last updated
- 2023-06-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02913794. Inclusion in this directory is not an endorsement.